This article is part of our online news archive

Radiotherapy between or during chemotherapy cycles reduces risk of breast cancer recurrence

A major UK trial led by the University has produced firm evidence that giving radiotherapy between or during chemotherapy cycles to women with early breast cancer significantly reduces the risk of the cancer recurring in the breast or chest wall. The treatment, known as synchronous chemoradiation, has minimal adverse side-effects and no detrimental effect on the patients' quality of life.

University of Birmingham Aston Webb building